FDA Approved: BACLOFEN — Original Application (Nexus Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Nexus Pharmaceuticals LLC's original ANDA for baclofen, a generic treatment for spasticity conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity
• Spasticity Due to Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

ORIG AP for BACLOFEN (BACLOFEN)